RaQualia Pharma Inc. announced consolidated earnings results for the first quarter ended March 31, 2021. For the quarter, the company reported net sales were ¥655 million against ¥123 million a year ago. Operating profit was ¥149 million against operating loss of ¥273 million a year ago. Profit was ¥188 million against loss of ¥328 million a year ago. Basic earnings per share was ¥9.00 against basic loss per share of ¥15.66 a year ago.